China National Medicines Corporation Ltd. (600511.SS)
CNY 28.99
(0.1%)
CNY 28.99
(0.1%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 2.94 Billion CNY | -12.17% |
| 2022 | 2.69 Billion CNY | 10.12% |
| 2021 | 2.44 Billion CNY | 27.91% |
| 2020 | 1.91 Billion CNY | -21.46% |
| 2019 | 2.43 Billion CNY | 19.51% |
| 2018 | 2.03 Billion CNY | 15.18% |
| 2017 | 1.76 Billion CNY | 154.68% |
| 2016 | 694.91 Million CNY | 9.74% |
| 2015 | 633.26 Million CNY | 8.55% |
| 2014 | 583.4 Million CNY | 33.59% |
| 2013 | 436.71 Million CNY | 49.07% |
| 2012 | 292.95 Million CNY | 22.06% |
| 2011 | 240 Million CNY | -34.81% |
| 2010 | 368.18 Million CNY | 35.02% |
| 2009 | 272.68 Million CNY | 23.41% |
| 2008 | 220.96 Million CNY | 13.65% |
| 2007 | 194.43 Million CNY | 67.5% |
| 2006 | 116.07 Million CNY | 60.35% |
| 2005 | 72.38 Million CNY | 21.15% |
| 2004 | 59.75 Million CNY | 8.34% |
| 2003 | 55.15 Million CNY | 19.31% |
| 2002 | 46.22 Million CNY | 32.14% |
| 2001 | 34.98 Million CNY | 34.88% |
| 2000 | 25.93 Million CNY | 46.21% |
| 1999 | 17.73 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 554.02 Million CNY | -9.74% |
| 2024 Q1 | 613.79 Million CNY | -16.3% |
| 2024 Q3 | 659.65 Million CNY | 19.07% |
| 2023 Q2 | 749.48 Million CNY | 30.68% |
| 2023 Q1 | 573.52 Million CNY | -20.87% |
| 2023 FY | 2.36 Billion CNY | -12.17% |
| 2023 Q4 | 733.35 Million CNY | 9.33% |
| 2023 Q3 | 670.79 Million CNY | -10.5% |
| 2022 Q3 | 778.73 Million CNY | 16.88% |
| 2022 Q1 | 525.16 Million CNY | -18.52% |
| 2022 Q4 | 724.78 Million CNY | -6.93% |
| 2022 FY | 2.69 Billion CNY | 10.12% |
| 2022 Q2 | 666.24 Million CNY | 26.86% |
| 2021 Q3 | 752.47 Million CNY | 18.27% |
| 2021 FY | 2.44 Billion CNY | 27.91% |
| 2021 Q2 | 636.25 Million CNY | 53.67% |
| 2021 Q1 | 414.03 Million CNY | -20.8% |
| 2021 Q4 | 644.51 Million CNY | -14.35% |
| 2020 Q2 | 504.21 Million CNY | 50.64% |
| 2020 Q4 | 522.74 Million CNY | -5.22% |
| 2020 FY | 1.91 Billion CNY | -21.46% |
| 2020 Q1 | 334.72 Million CNY | -58.83% |
| 2020 Q3 | 551.53 Million CNY | 9.38% |
| 2019 Q2 | 709.78 Million CNY | 72.46% |
| 2019 Q1 | 411.57 Million CNY | -36.17% |
| 2019 Q4 | 813.1 Million CNY | 62.1% |
| 2019 FY | 2.43 Billion CNY | 19.51% |
| 2019 Q3 | 501.61 Million CNY | -29.33% |
| 2018 Q2 | 579.62 Million CNY | 62.97% |
| 2018 Q3 | 458.36 Million CNY | -20.92% |
| 2018 Q1 | 355.66 Million CNY | -28.83% |
| 2018 Q4 | 644.8 Million CNY | 40.68% |
| 2018 FY | 2.03 Billion CNY | 15.18% |
| 2017 Q4 | 499.7 Million CNY | 12.56% |
| 2017 Q1 | 191.36 Million CNY | 29.75% |
| 2017 Q2 | 634.77 Million CNY | 231.71% |
| 2017 Q3 | 443.95 Million CNY | -30.06% |
| 2017 FY | 1.76 Billion CNY | 154.68% |
| 2016 FY | 694.91 Million CNY | 9.74% |
| 2016 Q2 | 201.1 Million CNY | 24.96% |
| 2016 Q1 | 160.93 Million CNY | 11.0% |
| 2016 Q4 | 147.48 Million CNY | -20.45% |
| 2016 Q3 | 185.38 Million CNY | -7.82% |
| 2015 Q4 | 144.99 Million CNY | -12.35% |
| 2015 FY | 633.26 Million CNY | 8.55% |
| 2015 Q3 | 165.42 Million CNY | -11.43% |
| 2015 Q2 | 186.77 Million CNY | 37.25% |
| 2015 Q1 | 136.07 Million CNY | 7.42% |
| 2014 FY | 583.4 Million CNY | 33.59% |
| 2014 Q2 | 176.81 Million CNY | 48.19% |
| 2014 Q1 | 119.31 Million CNY | 46.83% |
| 2014 Q4 | 126.67 Million CNY | -21.12% |
| 2014 Q3 | 160.59 Million CNY | -9.18% |
| 2013 Q3 | 143.56 Million CNY | 23.09% |
| 2013 Q2 | 116.63 Million CNY | 22.44% |
| 2013 Q1 | 95.25 Million CNY | 70.9% |
| 2013 FY | 436.71 Million CNY | 49.07% |
| 2013 Q4 | 81.26 Million CNY | -43.39% |
| 2012 Q4 | 55.73 Million CNY | -42.05% |
| 2012 Q1 | 77.35 Million CNY | 355.65% |
| 2012 Q2 | 63.67 Million CNY | -17.68% |
| 2012 Q3 | 96.18 Million CNY | 51.05% |
| 2012 FY | 292.95 Million CNY | 22.06% |
| 2011 FY | 240 Million CNY | -34.81% |
| 2011 Q1 | 78.83 Million CNY | 28.77% |
| 2011 Q4 | -30.25 Million CNY | -130.79% |
| 2011 Q3 | 98.26 Million CNY | 5.47% |
| 2011 Q2 | 93.16 Million CNY | 18.19% |
| 2010 Q4 | 61.21 Million CNY | -51.06% |
| 2010 FY | 368.18 Million CNY | 35.02% |
| 2010 Q3 | 125.08 Million CNY | 33.59% |
| 2010 Q2 | 93.62 Million CNY | 6.09% |
| 2010 Q1 | 88.25 Million CNY | 91.15% |
| 2009 Q1 | 76.35 Million CNY | 126.08% |
| 2009 Q4 | 46.17 Million CNY | -33.65% |
| 2009 FY | 272.68 Million CNY | 23.41% |
| 2009 Q3 | 69.59 Million CNY | -13.62% |
| 2009 Q2 | 80.56 Million CNY | 5.51% |
| 2008 FY | 220.96 Million CNY | 13.65% |
| 2008 Q4 | 33.77 Million CNY | -43.3% |
| 2008 Q3 | 59.56 Million CNY | -7.02% |
| 2008 Q2 | 64.05 Million CNY | 0.77% |
| 2008 Q1 | 63.56 Million CNY | 95.64% |
| 2007 Q4 | 32.49 Million CNY | -39.91% |
| 2007 Q1 | 54.38 Million CNY | 211.6% |
| 2007 Q2 | 53.48 Million CNY | -1.65% |
| 2007 FY | 194.43 Million CNY | 67.5% |
| 2007 Q3 | 54.07 Million CNY | 1.09% |
| 2006 Q1 | 33.98 Million CNY | 174.42% |
| 2006 FY | 116.07 Million CNY | 60.35% |
| 2006 Q4 | 17.45 Million CNY | -46.63% |
| 2006 Q3 | 32.7 Million CNY | 2.38% |
| 2006 Q2 | 31.93 Million CNY | -6.01% |
| 2005 FY | 72.38 Million CNY | 21.15% |
| 2005 Q4 | 12.38 Million CNY | -25.27% |
| 2005 Q1 | 26.49 Million CNY | 106.9% |
| 2005 Q3 | 16.57 Million CNY | -1.88% |
| 2005 Q2 | 16.88 Million CNY | -36.24% |
| 2004 Q4 | 12.8 Million CNY | -11.09% |
| 2004 Q3 | 14.4 Million CNY | 17.66% |
| 2004 FY | 59.75 Million CNY | 8.34% |
| 2004 Q2 | 12.23 Million CNY | -39.74% |
| 2004 Q1 | 20.3 Million CNY | 113.4% |
| 2003 Q2 | 15.15 Million CNY | -8.59% |
| 2003 Q1 | 16.57 Million CNY | 182.99% |
| 2003 FY | 55.15 Million CNY | 19.31% |
| 2003 Q4 | 9.51 Million CNY | -31.58% |
| 2003 Q3 | 13.9 Million CNY | -8.2% |
| 2002 Q4 | 5.85 Million CNY | -61.89% |
| 2002 Q3 | 15.36 Million CNY | -5.69% |
| 2002 FY | 46.22 Million CNY | 32.14% |
| 2002 Q2 | 16.29 Million CNY | 87.2% |
| 2002 Q1 | 8.7 Million CNY | 0.0% |
| 2001 FY | 34.98 Million CNY | 34.88% |
| 2000 FY | 25.93 Million CNY | 46.21% |
| 1999 FY | 17.73 Million CNY | 0.0% |